Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 115 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Physical Therapy Evaluation Clear all

Conditions: Cervical Radiculopathy, Cervical Radicular Pain
Interventions: Cervical epidural steroid injection; Procedure
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 78 participants
Timeline: 2020 – 2022
U.S. locations: 2
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland

Conditions: Duchenne Muscular Dystrophy
Interventions: delandistrogene moxeparvovec, placebo; Genetic
Lead sponsor: Sarepta Therapeutics, Inc.; Industry
Eligibility: 4 Years to 7 Years · Male only
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 23
States / cities: Little Rock, Arkansas • La Jolla, California • Los Angeles, California + 20 more

Conditions: Influenza
Interventions: CR8020, CR6261, Placebo; Biological
Lead sponsor: Crucell Holland BV; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 21
States / cities: Fresno, California • Stanford, California • Washington D.C., District of Columbia + 18 more

Conditions: Hypertension
Interventions: olmesartan medoxomil, placebo; Drug
Lead sponsor: Daiichi Sankyo; Industry
Eligibility: 1 Year to 16 Years
Enrollment: 362 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 28
States / cities: Birmingham, Alabama • Phoenix, Arizona • Little Rock, Arkansas + 25 more

Conditions: Deep Vein Thrombosis (DVT), Thrombus in the Peripheral Venous Vasculature, Venous Embolism, Thrombus in the Central and Peripheral Circulatory System, Including Saphenous Vein Grafts
Interventions: Aspiration thrombectomy system; Device
Lead sponsor: Argon Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 4
States / cities: Fort Lauderdale, Florida • Indianapolis, Indiana • Edgewood, Kentucky + 1 more

Conditions: Attention Deficit Hyperactivity Disorder
Interventions: Atomoxetine Hydrochloride, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 6 Years to 12 Years
Enrollment: 282 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2004
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Diffuse Large B-Cell Lymphoma (DLBCL)
Interventions: Mosunetuzumab, ClonoSEQ; Drug · Device
Lead sponsor: Danielle Wallace; Other
Eligibility: 70 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Diabetic Macular Edema
Interventions: Intravitreal ranibizumab 0.3mg; Drug
Lead sponsor: California Retina Consultants; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 6
States / cities: Bakersfield, California • Oxnard, California • Palmdale, California + 3 more

Conditions: Breast Cancer Female
Interventions: Not listed
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older · Female only
Enrollment: 575 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2030
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Care Delivery, Geriatrics, Geriatric Assessment
Interventions: Cancer care delivery; Other
Lead sponsor: Fox Chase Cancer Center; Other
Eligibility: 65 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Acne-prone Skin, Skin Disease
Interventions: PRX S topical cosmetic treatment, WiQo home care regimen (Nourishing Cream; Balancing Cream); Other
Lead sponsor: WiQo S.p.A.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 2
States / cities: Leawood, Kansas • Tulsa, Oklahoma

Conditions: Low Back Pain, Herniation, Disc, Sciatic Radiculopathy, Intervertebral Disc Stenosis of Neural Canal, Intervertebral Disc Injury
Interventions: NSSD, Sham NSSD; Device
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Stanford, California • Tampa, Florida

Conditions: Hypertrophic Scars Resulting From Prior Breast Scar Revision Surgery
Interventions: PF-06473871; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 57 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 5
States / cities: Coral Gables, Florida • Miami, Florida • Atlanta, Georgia + 1 more

Conditions: Vestibular Disorder, Balance; Distorted, Vestibular Diseases
Interventions: Vestibular rehabilitation app, Traditional Physical Therapy; Device · Other
Lead sponsor: CFD Research Corporation; Industry
Eligibility: 60 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Vascular Diseases
Interventions: Virtual visit; Procedure
Lead sponsor: CAMC Health System; Other
Eligibility: 18 Years to 90 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Physiological Measurements of Response and Reaction Times
Interventions: Chiropractic Manipulative Therapy, Wait-list; Other
Lead sponsor: RAND; Other
Eligibility: 20 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Fort Campbell North, Kentucky

Conditions: Wrinkle
Interventions: Tixel, Laser; Device
Lead sponsor: Novoxel Ltd.; Industry
Eligibility: 40 Years to 70 Years
Enrollment: 68 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: New York, New York

Conditions: Amyotrophic Lateral Sclerosis
Interventions: Tirasemtiv, Placebo tablets; Drug
Lead sponsor: Cytokinetics; Industry
Eligibility: 18 Years and older
Enrollment: 744 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 49
States / cities: Phoenix, Arizona • La Jolla, California • Los Angeles, California + 42 more

Conditions: Safety Issues
Interventions: Not listed
Lead sponsor: Parker University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 161 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Neoplasms
Interventions: Mind-Body Psychotherapy Group; Behavioral
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Multiple Sclerosis
Interventions: Group wellness intervention, Individualized physical rehabilitation; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Pain
Interventions: interscalene catheter, interscalene block; Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 79 Years
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 2
States / cities: Madison, Wisconsin

Conditions: Stroke, Cerebrovascular Disorders, Brain Ischemia, Infarction
Interventions: Accelerated Skill Acquisition Program (ASAP), Active Monitoring; Behavioral
Lead sponsor: University of Southern California; Other
Eligibility: 21 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pediatric Solid Tumor
Interventions: Genetic testing and GAIN report; Genetic
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: Up to 30 Years
Enrollment: 825 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2026
U.S. locations: 12
States / cities: San Francisco, California • Aurora, Colorado • Washington D.C., District of Columbia + 8 more

Search by objective public record fields.

Non-organic Signs to Predict Outcomes for Neck Pain

A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

Assessment of Efficacy of CR8020 and CR6261, Monoclonal Antibodies, Against Influenza Infection

Assessment of Efficacy and Safety of Olmesartan Medoxomil in Children and Adolescent Patients With High Blood Pressure

Cleaner Long-tErm Assessment Registry - Venous Insights and Efficacy With eXtended Tracking

Evaluation of Continuous Symptom Treatment of ADHD

A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

Performance Assessment Tests in Working Individuals With DME Following Treatment With Ranibizumab

Assessment of Breast Cancer Patients Satisfaction and Health Related Quality of Life Outcomes

Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.

Observational Assessment of Skin Appearance Changes During PRX S Cosmetic Treatment in Participants With Acne-Prone Skin

Non-surgical Spinal Decompression Therapy and Outcomes

A Phase 2 Extension Study To Enroll Subjects Who Were Enrolled In B5301001 Study

Individualized Vestibular Rehabilitation for Elderly With Self-Management and Gaming Elements

Virtual and Physical Health Assessments and Treatment Plans

Assessment of Chiropractic Treatment Using Reaction and Response Times in Members of the Special Operation Forces (ACT2)

A Safety and Effectiveness Study of the Tixel Device, (Fractional Peri-orbital Wrinkles Treatment ) Compared With Laser

Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year

MIST3: Active Patient Safety Reporting

Mind-Body Program for Cancer Patients

Promoting Physical Activity for Persons With Multiple Sclerosis

Prospective Evaluation of Interscalene Nerve Catheters vs. Single Injection Blocks

Dose Optimization for Stroke Evaluation

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study